Richard McCrary
Pediatrics · Gulfport, MSNPI 1265547301
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 197 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Among pediatrics clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 197 payments — averaging $18.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$671
- Ironshore Pharmaceuticals Inc.$609
- Tris Pharma Inc$560
- Supernus Pharmaceuticals, Inc.$512
- Merck$209
- GSK$162
- plus $936 from 16 others
What the payments were for
- Consulting fees$251%
- Food & beverage$3,63399%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 39 | $671 |
| Ironshore Pharmaceuticals Inc. | 38 | $609 |
| Tris Pharma Inc | 37 | $560 |
| Supernus Pharmaceuticals, Inc. | 34 | $512 |
| Merck | 4 | $209 |
| GSK | 10 | $162 |
| Sanofi Pasteur Inc. | 7 | $139 |
| PTC Therapeutics, Inc. | 1 | $129 |
| AstraZeneca(2 entities) | 2 | $125 |
| Sanofi | 1 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $99 |
| Pfizer | 4 | $70 |
| Adlon Therapeutics L.p. | 3 | $36 |
| Neos Therapeutics, LP | 2 | $36 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| Shire North American Group Inc | 2 | $33 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Seqirus USA Inc | 1 | $21 |
| Genentech USA, Inc. | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| Harmony Biosciences LLC | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,658 in reported general payments places this provider in the 95th percentile of 419 pediatrics providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Risperidone | 16 | $80 |
| Ezetimibe | 12 | $42 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Gulfport
- Madelena CampbellGulfport$6K
- Angela OstrowskiGulfport$5K
- Maureen HollandGulfport$4K
- Catherine DonaldGulfport$2K
- Dereck DavisJackson$20K
- Tami BrooksJackson$14K
- Thomas IrelandTupelo$11K
- Denise PowellBay St Louis$7K
- Jonathan ShookHattiesburg$5K
- Elizabeth FelderHattiesburg$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.